Cover Image
市場調查報告書

腫瘤切除的全球市場:市場考察,機會,分析,市場佔有率,預測

Global Tumor Ablation Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 539041
出版日期 內容資訊 英文 190 Pages
商品交期: 請詢問到貨日
價格
Back to Top
腫瘤切除的全球市場:市場考察,機會,分析,市場佔有率,預測 Global Tumor Ablation Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023
出版日期: 2017年06月07日 內容資訊: 英文 190 Pages
簡介

本報告提供腫瘤切除的全球市場調查,整體市場趨勢,及各適應、技術、治療方法、地區的詳細趨勢,市場規模、成長率的變化與預測,市場促進、阻礙因素以及市場機會、課題分析,競爭情形,主要企業簡介等系統性資訊。

第1章 簡介

第2章 市場概要

  • 腫瘤切除的全球市場:發展和變遷
  • 市場定義 & 範圍
  • 產業結構
  • 法律規範
  • 市場分析
  • 預測分析
  • 策略分析
    • 投資 vs 引進模式
    • 全方位的產業分析
    • 波特的五力分析
    • Seesaw分析
    • 消費者分析 & 購買標準
  • 競爭分析
    • 主要策略
    • 市場佔有率分析
  • 策略建議
    • 各地區的投資機會
    • 新用途的市場機會
    • 最快成長市場上投資機會

第3章 市場決策要素

  • 市場的推動要素
  • 市場阻礙因素
  • 市場機會
  • 市場課題

第4章 市場區隔

  • 腫瘤切除的全球市場:各適應症
    • 肝癌
    • 腎臟癌
    • 肺癌
    • 骨轉移
    • 其他
  • 腫瘤切除的全球市場:各技術
    • 射頻消融術
    • 冷凍切除(冷凍治療)
    • 微波切除
    • 其他
  • 腫瘤切除的全球市場:各治療法
    • 腹腔鏡下切除
    • 經皮心導管電氣燒灼術
    • 外科切除

第5章 競爭情形

  • 主要策略
    • 合併、收購
    • 合資企業
    • 新產品的銷售
    • 夥伴關係

第6章 地區分析

  • 意思支援資料庫 & 估計手法
  • 產業間比較分析
  • 市場機會矩陣
  • 腫瘤切除的全球市場:各地區
    • 北美
      • 產業分析
      • 各國
    • 歐洲
      • 產業分析
      • 各國
    • 亞太地區
      • 產業分析
      • 各國
    • 其他地區
      • 產業分析
      • 各地區

第7章 企業簡介

目錄
Product Code: HME-5930617

The global tumor ablation market is expected to grow with the CAGR of approximately 12.8% during the forecast period (2016-2023). The market growth is primarily driven due to various factors such as increasing awareness regarding ablation procedures, increasing prevalence of cancer across the globe, technological innovations in thermal ablation technologies and increasing adoption of radiofrequency ablation. The radiofrequency ablation technology is expected to grow with the CAGR of approximately10.8% during the forecast period (2016-2023). Increasing awareness regarding the benefits associated with tumor ablation via. Radiofrequency such as its effectiveness, low risk of tissue damage as well as faster recovery is expected to propel its demand significantly in the forecast period. According to Radiology Info, RFA is a potential treatment option regarding patients who have problem with surgery and those, whose tumors are smaller than one and a half inch in diameter. The achievement rate for fully eliminating small liver tumors is higher than 85%.

Radiofrequency ablation is a feasible and effective option for the treatment and tumor ablation is a better option if surgery is not possible or risky or would not have sufficient liver tissue left for the organ in order to function sufficiently by following the surgical removal of a tumor. Furthermore, surgery is also risky in liver tumors that have not reacted to chemotherapy as well as small liver tumors which are excessively spread out to be eliminated surgically. The use of radiofrequency ablation technology is increasing its popularity that is also expected to enhance its adoption rate in the upcoming years. However, strict government regulations and high cost associated with the technology are hindering the growth of tumor ablation market. Increasing healthcare infrastructure in developing countries and increasing medical tourism across the globe is expected to create good opportunity for the market growth. On the basis of geography, North America occupied major share, in terms of revenue in 2016 due to increasing expenditure for healthcare services in the region as well as increasing prevalence of cancer in the region. However, Asia Pacific is expected to be the fastest growing region for the tumor ablation market due to increasing awareness regarding minimally-invasive procedures in the region as well as increasing government focus to develop better healthcare infrastructure in the region. The presence of major players such as Boston Scientific Corporation (U.S.), Ethicon, Inc. (U.S.), Health Tronics, Inc. (U.S.), Integra Lifesciences Holdings Corporation (U.S.), Medtronic PLC (U.S.) etc. are creating opportunity for large innovations in tumor ablation therapies which will further increase demand of tumor ablation therapies.

The global tumor ablation market is segmented on the basis of application, technology and mode of treatment. The application segment is further categorized into liver cancer, kidney cancer, lung cancer, bone metastasis and others. The technology segment is further classified into radiofrequency (RF) ablation, cryoablation, microwave ablation and other technologies. The mode of treatment is further segmented into laparoscopic ablation, percutaneous ablation, and surgical ablation.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL TUMOR ABLATION MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES & ANALYSIS
    • 2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. INCREASING AWARENESS REGARDING ABLATION PROCEDURES
    • 3.1.2. INCREASING PREVALENCE OF CANCER ACROSS THE GLOBE
    • 3.1.3. TECHNOLOGICAL ADVANCEMENTS IN ABLATION DEVICES
    • 3.1.4. INCREASING ADOPTION OF RADIOFREQUENCY ABLATION
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. STRICT GOVERNMENT REGULATIONS
    • 3.2.2. HIGH COST ASSOCIATED WITH THE TECHNOLOGY
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. INCREASING HEALTHCARE INFRASTRUCTURE IN DEVELOPING COUNTRIES
    • 3.3.2. INCREASING MEDICAL TOURISM ACROSS THE GLOBE
  • 3.4. MARKET CHALLENGES
    • 3.4.1. LACK OF SKILLED PROFESSIONALS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL TUMOR ABLATION MARKET BY APPLICATION
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL TUMOR ABLATION MARKET IN LIVER CANCER
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL TUMOR ABLATION MARKET IN KIDNEY CANCER
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL TUMOR ABLATION MARKET IN LUNG CANCER
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
      • 4.1.5.4. GLOBAL TUMOR ABLATION MARKET IN BONE METASTASIS
        • 4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.4.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.4.4. KEY CONCLUSIONS
      • 4.1.5.5. GLOBAL TUMOR ABLATION MARKET IN OTHERS
        • 4.1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.5.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.5.4. KEY CONCLUSIONS
  • 4.2. GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL RADIOFREQUENCY (RF) ABLATION MARKET
        • 4.2.5.1.1. APPLICATION
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL CRYOABLATION MARKET
        • 4.2.5.2.1. APPLICATION
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
      • 4.2.5.3. GLOBAL MICROWAVE ABLATION MARKET
        • 4.2.5.3.1. APPLICATION
        • 4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. KEY CONCLUSIONS
      • 4.2.5.4. GLOBAL OTHER TECHNOLOGIES MARKET
        • 4.2.5.4.1. APPLICATION
        • 4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.4.5. KEY CONCLUSIONS
  • 4.3. GLOBAL TUMOR ABLATION MARKET BY MODE OF TREATMENT
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL LAPAROSCOPIC ABLATION MARKET
        • 4.3.5.1.1. APPLICATION
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL PERCUTANEOUS ABLATION MARKET
        • 4.3.5.2.1. APPLICATION
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
      • 4.3.5.3. GLOBAL SURGICAL ABLATION MARKET
        • 4.3.5.3.1. APPLICATION
        • 4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS & ACQUISITIONS
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL TUMOR ABLATION MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRIAL ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ANGIODYNAMICS, INC. (U.S.)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
    • 7.1.6. STRATEGIC ANALYSIS
  • 7.2. BOSTON SCIENTIFIC CORPORATION (U.S.)
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
    • 7.2.6. STRATEGIC ANALYSIS
  • 7.3. BTG INTERNATIONAL LTD (UK)
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
    • 7.3.6. STRATEGIC ANALYSIS
  • 7.4. BVM MEDICAL LTD (UK)
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
    • 7.4.6. STRATEGIC ANALYSIS
  • 7.5. COMSOL, INC. (U.S.)
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
  • 7.6. EDAP TMS S.A. (FRANCE)
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
    • 7.6.6. STRATEGIC ANALYSIS
  • 7.7. ETHICON, INC. (U.S.)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
    • 7.7.6. STRATEGIC ANALYSIS
  • 7.8. GALIL MEDICAL, INC. (U.S.)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
    • 7.8.6. STRATEGIC ANALYSIS
  • 7.9. HEALTH TRONICS, INC. (U.S.)
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
    • 7.9.6. STRATEGIC ANALYSIS
  • 7.10. INTEGRA LIFESCIENCES HOLDINGS CORPORATION (U.S.)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
    • 7.10.6. STRATEGIC ANALYSIS
  • 7.11. INTIO, INC. (U.S.)
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
    • 7.11.6. STRATEGIC ANALYSIS
  • 7.12. MEDTRONIC PLC (U.S.)
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
    • 7.12.6. STRATEGIC ANALYSIS
  • 7.13. MERMAIL MEDICAL A/S (DENMARK)
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
    • 7.13.6. STRATEGIC ANALYSIS
  • 7.14. SONACARE MEDICAL A/S (U.S.)
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
    • 7.14.6. STRATEGIC ANALYSIS
  • 7.15. ST. JUDE MEDICAL, INC. (U.S.)
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS
    • 7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

  • TABLE 1. GLOBAL TUMOR ABLATION MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • TABLE 2. GLOBAL TUMOR ABLATION MARKET FOR LIVER CANCER BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 3. GLOBAL TUMOR ABLATION MARKET FOR KIDNEY CANCER BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 4. GLOBAL TUMOR ABLATION MARKET FOR LUNG CANCER BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 5. GLOBAL TUMOR ABLATION MARKET FOR BONE MESTASIS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 6. GLOBAL TUMOR ABLATION MARKET FOR OTHERS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 7. GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
  • TABLE 8. GLOBAL RADIOFREQUENCY (RF) ABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 9. GLOBAL CRYOABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 10. GLOBAL MICROWAVE ABLATION MARKET BY PLATFORM 2014-2023 ($ MILLION)
  • TABLE 11. GLOBAL OTHER TECHNOLOGIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 12. GLOBAL TUMOR ABLATION MARKET BY MODE OF TREATMENT 2014-2023 ($ MILLION)
  • TABLE 13. GLOBAL LAPAROSCOPIC ABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS ABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 15. GLOBAL SURGICAL ABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 16. NORTH AMERICA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • TABLE 17. EUROPE TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • TABLE 18. ASIA PACIFIC TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • TABLE 19. REST OF THE WORLD TUMOR ABLATION MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1. GLOBAL TUMOR ABLATIONMARKET BY LIVER CANCER 2014-2023 ($ MILLION)
  • FIGURE 2. GLOBAL TUMOR ABLATION MARKET BY KIDNEY CANCER 2014-2023 ($ MILLION)
  • FIGURE 3. GLOBAL TUMOR ABLATION MARKET BY LUNG CANCER 2014-2023 ($ MILLION)
  • FIGURE 4. GLOBAL TUMOR ABLATION MARKET BY BONE MESTASIS 2014-2023 ($ MILLION)
  • FIGURE 5. GLOBAL TUMOR ABLATION MARKET BY OTHERS 2014-2023 ($ MILLION)
  • FIGURE 6. GLOBAL TUMOR ABLATION MARKET BY RADIOFREQUENCY (RF) ABLATION 2014-2023 ($ MILLION)
  • FIGURE 7. GLOBAL TUMOR ABLATION MARKET BY CRYOABLATION 2014-2023 ($ MILLION)
  • FIGURE 8. GLOBAL TUMOR ABLATION MARKET BY MICROWAVE ABLATION 2014-2023 ($ MILLION)
  • FIGURE 9. GLOBAL TUMOR ABLATION MARKET BY OTHER TECHNOLOGIES 2014-2023 ($ MILLION)
  • FIGURE 10. GLOBAL TUMOR ABLATION MARKET BY LAPAROSCOPIC ABLATION 2014-2023 ($ MILLION)
  • FIGURE 11. GLOBAL TUMOR ABLATION MARKET BY PERCUTANEOUS ABLATION 2014-2023 ($ MILLION)
  • FIGURE 12. GLOBAL TUMOR ABLATION MARKET BY SURGICAL ABLATION 2014-2023 ($ MILLION)
  • FIGURE 13. UNITED STATES (U.S.) TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 14. CANADA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 15. UNITED KINGDOM (UK) TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 16. FRANCE TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 17. GERMANY TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 18. SPAIN TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 19. ROE TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 20. INDIA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 21. CHINA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 22. JAPAN TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 23. AUSTRALIA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 24. ROAPAC TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 25. LATIN AMERICA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
  • FIGURE 26. MENA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
Back to Top